Saskatchewan Winters Last updated: Mon 04 Feb 2008 11:19 PM CST
Saskatchewan Blizzard
View Article  Trial with Tovaxin™ for Multiple Sclerosis

Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin™ for Multiple Sclerosis

 

Effectiveness Shown in Relapsing Remitting Subjects Across Both ...   more »

View Article  Multiple Sclerosis Patients Benefit From High Dose, High Frequency Interferon Beta

Multiple Sclerosis Patients Benefit From High Dose, High Frequency Interferon Beta

 

 

Patients with relapsing- remitting multiple sclerosis (MS), the most common form of ...   more »

View Article  Depression Not Related to Disease Modifying Therapy in Multiple Sclerosis

Depression Not Related to Disease Modifying Therapy in Multiple Sclerosis: Presented at ENS

 

 RHODES, GREECE

 

 

Patients with multiple sclerosis (MS) often ...   more »

View Article  Bonnie - Spinal Tap

Drinking coke at 7:00 AM in the morning, on the day of my Lumbar Puncture, was difficult.  I arrived at the hospital at 8:00 A.M. ...   more »

View Article  The use of stem cells for the treatment of autoimmune diseases.

The use of stem cells for the treatment of autoimmune diseases.

 Autoimmune diseases constitute a heterogeneous group of conditions commonly treated with anti-inflammatory, immunosuppressant, ...   more »

View Article  placebo-controlled trial of natalizumab in relapsing MS.

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

 

Institute of Neurology,

University College London,

London, UK.

 

    BACKGROUND:

 ...   more »

View Article  'CARS' (coherent anti-Stokes Raman scattering) imaging reveals clues to myelin damage


'CARS' imaging reveals clues to myelin damage

WEST LAFAYETTE, Ind. –

Purdue University

 

Researchers have discovered that calcium ions could play a crucial role ...   more »

View Article  Response to Interferon Beta Therapy in a Cohort of Relapsing-remitting Multiple Sclerosis

Response to Interferon Beta Therapy in a Cohort of Relapsing-remitting Multiple Sclerosis

 

RHODES, GREECE –

 

Magnetic resonance imaging (MRI) of brain lesions at ...   more »

View Article  Men and Women Equally Transmit Genetic Risk of MS to Their Children

Men and Women Equally Transmit Genetic Risk of MS to Their Children

 

ST. PAUL, MN

 

 Men and women with multiple sclerosis (MS) ...   more »

View Article  Fish Oil Could Provide Measure of Relief for Some MS Patients

Fish Oil Could Provide Measure of Relief for Some MS Patients

 

Description:

 

New findings confirm previous research findings that suggest the intake of ...   more »

View Article  Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study.

Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study.

The International Multiple Sclerosis Genetics Consortium.

 
BACKGROUND:

 

Multiple sclerosis has a clinically significant ...   more »

View Article  Interferon beta in secondary progressive multiple sclerosis (SPMS)

Interferon beta in secondary progressive multiple sclerosis

Daily clinical practice

Journal of Neurology

 

Barcelona, Spain

 

 

Background and objective:

 

Observational studies may ...   more »

View Article  Neutralising antibodies to interferon in MS

Abstract Interferon beta (IFNβ) therapy for multiple sclerosis (MS) is associated with a potential for the development of neutralising antibodies (NAbs) that negatively affect therapy. ...   more »

View Article  DNA Vaccine Against Multiple Sclerosis Appears Safe

DNA Vaccine Against Multiple Sclerosis Appears Safe, Potentially Beneficial

 

CHICAGO, IL –

August 13, 2007 –

 

A newly developed DNA vaccine appears safe ...   more »

View Article  Study: Betaseron vs Copaxone in MS

Study:  Betaseron vs Copaxone in MS


Head-to-head comparison of interferon beta-1b (Betaseron, Bayer HealthCare Pharmaceuticals [erstwhile Berlex]) and glatiramer acetate (Copaxone...   more »